PATHAI
PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time. The company was founded in 2016 and based in Boston, Massachusetts.
PATHAI
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.pathai.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
255.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-26 | Poplar Healthcare | Poplar Healthcare acquired by PathAI | N/A |
Investors List
General Atlantic
General Atlantic investment in Series C - PathAI
LabCorp
LabCorp investment in Series C - PathAI
General Catalyst
General Catalyst investment in Series C - PathAI
Adage Capital Management
Adage Capital Management investment in Series C - PathAI
Refactor Capital
Refactor Capital investment in Series C - PathAI
Kaiser Permanente
Kaiser Permanente investment in Series C - PathAI
Bienville Capital
Bienville Capital investment in Series C - PathAI
Biospring Partners
Biospring Partners investment in Series C - PathAI
Bristol Myers Squibb
Bristol Myers Squibb investment in Series C - PathAI
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series C - PathAI
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | PathAI Appoints Brandon Eldredge as Chief Financial Officer |
| 2021-10-22 | PathAI Welcomes Two New Executives as it Strengthens its Biopharma Business Leadership Team |
Official Site Inspections
http://www.pathai.com Semrush global rank: 1.83 M Semrush visits lastest month: 12.4 K
- Host name: 104.18.11.32
- IP address: 104.18.11.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PathAI"
We Bring Powerful New Technologies to Pathology that can …
PathAI raised $165 million in Series C funding. This round fueled PathAI’s commercial reach in our research and development capabilities. 2021 - Expanded into Clinical Diagnostics PathAI …See details»
PathAI - Crunchbase Company Profile & Funding
PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. …See details»
PathAI Company Profile 2024: Valuation, Funding & Investors
PathAI was founded in 2016. Where is PathAI headquartered? PathAI is headquartered in Boston, MA. What is the size of PathAI? PathAI has 300 total employees. What industry is …See details»
PathAI - LinkedIn
PathAI | 58,561 followers on LinkedIn. Improving patient outcomes with AI-powered pathology. | PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises ...See details»
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI …
May 1, 2024 The adoption of these technologies by an organization with the scale and breadth of capabilities of Quest is a clear demonstration of how PathAI's cutting-edge solutions can …See details»
Quest Diagnostics to Acquire PathAI Diagnostics to …
May 1, 2024 Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi ...See details»
PathAI - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. PathAI . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. PathAI has 12 current employee profiles, …See details»
PathAI | Company Overview & News - Forbes
PathAI does the same thing with artificial intelligence, sharing its analysis through a simple color system: cancer (red), surrounding cells (green) and dead cells (black). It's an extra pair of ...See details»
Quest Diagnostics to Acquire PathAI Diagnostics to …
May 1, 2024 The adoption of these technologies by an organization with the scale and breadth of capabilities of Quest is a clear demonstration of how PathAI's cutting-edge solutions can help address the ...See details»
PathAI - Funding, Financials, Valuation & Investors - Crunchbase
PathAI has acquired Poplar Healthcare on Jul 26, 2021. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 6. ... How much funding has this …See details»
Get In Touch - PathAI
Jun 11, 2024 PathAI remains an independent company, focused on developing innovative AI and digital pathology solutions SECAUCUS, NJ and BOSTON – June 11, 2024 – Quest …See details»
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI …
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and …See details»
PathAI enters into clinical diagnostics through acquisition of …
Jul 26, 2021 PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in …See details»
PathAI Announces Strategic Partnership with Roche to Enable …
Oct 15, 2021 About PathAI. PathAI is a leading provider of AI-powered research tools and services for pathology. ... More than thirty medicines developed by Roche are included in the …See details»
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI …
May 1, 2024 The adoption of these technologies by an organization with the scale and breadth of capabilities of Quest is a clear demonstration of how PathAI's cutting-edge solutions can …See details»
PathAI Announces Collaboration with the Crohn’s & Colitis …
Oct 3, 2024 BOSTON, MA / ACCESSWIRE / October 3, 2024 /PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced a partnership with the …See details»
PathAI Announces New Executive Appointment to Drive …
Jun 14, 2023 Matt Grow joins as president of biopharma and chief business officer BOSTON — June 14, 2023 — PathAI, a leading provider of AI-powered pathology tools to advance …See details»
PathAI Announces Collaboration with the Crohn’s & Colitis …
Oct 4, 2024 PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced a partnership with the Crohn’s & Colitis Foundation.The collaboration will …See details»
PathAI Commences New Year with Strong Foundation Following …
Boston, MA – January 16, 2023 – PathAI, a leadingAI-powered precision pathology company, has concluded a year marked by significant growth and advancements. The company developed …See details»